Seminars in Nephrology
Volume 25, Issue 6 , Pages 392-396 , November 2005

Anemia and Heart Failure in Chronic Kidney Disease

References 

  1. US Renal Data System . USRDS 2003 Annual Data Report . Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2003;
  2. Rayner HC , Pisoni RL , Bommer J , et al.   Mortality and hospitalization in haemodialysis patients in five European countries (Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)) . Nephrol Dial Transplant . 2004;19:108–120
  3. Foley RN , Parfrey PS , Harnett JD , et al.   Clinical and echocardiographic disease in patients starting end-stage renal disease therapy . Kidney Int . 1995;47:186–192
  4. US Renal Data System . 2002 Annual Data Report . Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2002;
  5. Locatelli F , Marcelli D , Conte F , et al.   Patient selection affects end-stage renal disease outcome comparisons . Kidney Int . 2000;57(suppl 74):94–99
  6. Locatelli F , Port FK , Pisoni RL , et al.   Patient and treatment characteristics in the MPO Study (validation against the DOPPS population) . Nephrol Dial Transplant . 2003;18(suppl 4):A196
  7. Levin A , Thompson CR , Ethier J , et al.   Left ventricular mass index increase in early renal disease (Impact of decline in hemoglobin) . Am J Kidney Dis . 1999;34:125–134
  8. Holland DC , Lam M . Predictors of hospitalization and death among pre-dialysis patients (A retrospective cohort study) . Nephrol Dial Transplant . 2000;15:650–658
  9. Astor BC , Muntner P , Levin A , et al.   Association of kidney function with anemia (The Third National Health and Nutrition Examination Survey (1988-1994)) . Arch Intern Med . 2002;162:1401–1408
  10. National Kidney Foundation . K/DOQI clinical practice guidelines. 2000 update . Am J Kidney Dis . 2001;37(suppl 1):S1–S238
  11. Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure . Nephrol Dial Transplant . 2004;19(suppl 2):1–47
  12. Obrador GT , Ruthazer R , Arora P , et al.   Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States . J Am Soc Nephrol . 1999;10:1793–1800
  13. Pisoni RL , Bragg-Gresham JL , Young EW , et al.   Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS) . Am J Kidney Dis . 2004;44:94–111
  14. Eckardt KU , Clyne N , Drueke T , et al.   Left ventricular hypertrophy and associated variables in the ‘Cardiovascular Risk Reduction by Early Anemia Treatment with Epoetin beta’ (CREATE) Trial . Nephrol Dial Transplant . 2003;18(suppl 4):A155
  15. London GM , Fabiani F , Marchais SJ , et al.   Uremic cardiomyopathy (An inadequate left ventricular hypertrophy) . Kidney Int . 1987;31:973–980
  16. Levin A , Singer J , Thompson CR , et al.   Prevalent left ventricular hypertrophy in the predialysis population (Identifying opportunities for intervention) . Am J Kidney Dis . 1996;27:347–354
  17. Foley RN , Parfrey PS , Harnett JD , et al.   The impact of anaemia on cardiomyopathy, morbidity and mortality in end-stage renal disease . Am J Kidney Dis . 1996;28:53–61
  18. Stack AG , Saran R . Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States . Am J Kidney Dis . 2002;40:1202–1210
  19. Jurkovitz CT , Abramson JL , Viola Vaccarino L , et al.   Association of high serum creatinine and anemia increases the risk of coronary events (Results from the prospective community-based Atherosclerosis Risk in Communities (ARIC) Study) . J Am Soc Nephrol . 2003;14:2919–2925
  20. Locatelli F , Conte F , Marcelli D . The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity—the experience of the Lombardy Dialysis Registry . Nephrol Dial Transplant . 1998;13:1642–1644
  21. Ma JZ , Ebben J , Xia H , et al.   Haematocrit level and associated mortality in haemodialysis patients . J Am Soc Nephrol . 1999;10:610–619
  22. Xia H , Ebben J , Ma JZ , et al.   Haematocrit level and hospitalizations risks in haemodialysis patients . J Am Soc Nephrol . 1999;10:1309–1316
  23. Collins AJ , Li S , St Peter W , et al.   Death, hospitalization and economic associations among incident hemodialysis patients with hematocrit values of 36-39% . J Am Soc Nephrol . 2001;12:2465–2473
  24. Locatelli F , Pisoni RL , Combe C , et al.   Anemia in haemodialysis patients of five European Countries (Association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)) . Nephrol Dial Transplant . 2004;19:121–132
  25. Portoles J , Torralbo A , Martin P , et al.   Cardiovascular effects of recombinant human erythropoietin in predialysis patients . Am J Kidney Dis . 1997;29:541–548
  26. Hayashi T , Suzuki A , Shoji T , et al.   Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure . Am J Kidney Dis . 2000;35:250–256
  27. Silverberg DS , Wexler D , Blum M , et al.   The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron . Nephrol Dial Transplant . 2003;18:141–146
  28. Frank H , Heusser K , Hoffken B , et al.   Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients . Kidney Int . 2004;66:832–840
  29. Besarab A , Bolton WK , Browne JK , et al.   The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin . N Engl J Med . 1998;339:584–590
  30. Foley RN , Parfrey PS , Morgan J , et al.   Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy . Kidney Int . 2000;58:1325–1335
  31. Roger SD , McMahon LP , Clarkson A , et al.   Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4) (Results of a randomized clinical trial) . J Am Soc Nephrol . 2004;15:148–156
  32. Macdougall IC . CREATE (New strategies for early anaemia management in renal insufficiency) . Nephrol Dial Transplant . 2003;18(suppl 2):ii13–ii16
  33. Laville M . Anaemia CORrection in Diabetes trial: New strategies in anaemia management: ACORD (Anaemia CORrection in Diabetes) trial . Acta Diabetol . 2004;41(suppl 1):S18–S22

PII: S0270-9295(05)00103-8

doi: 10.1016/j.semnephrol.2005.05.008

Seminars in Nephrology
Volume 25, Issue 6 , Pages 392-396 , November 2005

Article Tools